Albin Jeanne

Immunology and Microbiology · Life Sciences

13h-index875citations20works5.02yr avg
OpenAlex↗ORCID↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Phagocytosis and Immune Regulation(8), Angiogenesis and VEGF in Cancer(5), Protease and Inhibitor Mechanisms(5), Cell Adhesion Molecules Research(4), Immunotherapy and Immune Responses(2)

Publications20 total

The CD47/TSP-1 axis: a promising avenue for ovarian cancer treatment and biomarker research
Molecular Cancer·2024· 10 citedOpen Access
Targeting the CD47/TSP-1 axis: A promising strategy for patients with ovarian cancer (OC) that relapses on PARP inhibitors (PARPi).
Journal of Clinical Oncology·2024
Assessment of Ovarian Tumor Growth in Wild-Type and Lumican-Deficient Mice: Insights Using Infrared Spectral Imaging, Histopathology, and Immunohistochemistry
HAL (Le Centre pour la Communication Scientifique Directe)·2022Open Access
Assessment of Ovarian Tumor Growth in Wild-Type and Lumican-Deficient Mice: Insights Using Infrared Spectral Imaging, Histopathology, and Immunohistochemistry
Cancers·2021· 5 citedOpen Access
Targeting Ovarian Carcinoma with TSP-1:CD47 Antagonist TAX2 Activates Anti-Tumor Immunity
Cancers·2021· 36 citedOpen Access
Towards the Therapeutic Use of Thrombospondin 1/CD47 Targeting TAX2 Peptide as an Antithrombotic Agent
Arteriosclerosis Thrombosis and Vascular Biology·2020· 14 citedOpen Access
Deciphering the complex role of thrombospondin-1 in glioblastoma development
Nature Communications·2019· 225 citedOpen Access
Correction: Thrombospondin-targeting TAX2 peptide impairs tumor growth in preclinical mouse models of childhood neuroblastoma
Pediatric Research·2019Open Access
LRP1 expression in colon cancer predicts clinical outcome
Oncotarget·2018· 43 citedOpen Access
Identification of LRP-1 as an endocytosis and recycling receptor for β1-integrin in thyroid cancer cells
Oncotarget·2017· 29 citedOpen Access
Lumican delays melanoma growth in mice and drives tumor molecular assembly as well as response to matrix-targeted TAX2 therapeutic peptide
Scientific Reports·2017· 47 citedOpen Access
Thrombospondin-targeting TAX2 peptide impairs tumor growth in preclinical mouse models of childhood neuroblastoma
Pediatric Research·2016· 26 citedOpen Access
Matricellular TSP-1 as a target of interest for impeding melanoma spreading: towards a therapeutic use for TAX2 peptide
Clinical & Experimental Metastasis·2016· 31 cited
Original insights on thrombospondin-1-related antireceptor strategies in cancer
Frontiers in Pharmacology·2015· 95 citedOpen Access
Identification of TAX2 peptide as a new unpredicted anti-cancer agent
Oncotarget·2015· 39 citedOpen Access
Ethoxyfagaronine, a synthetic analogue of fagaronine that inhibits vascular endothelial growth factor-1, as a new anti-angiogeneic agent
Investigational New Drugs·2014· 9 cited
Low-Density Lipoprotein Receptor-Related Protein-1 Mediates Endocytic Clearance of Tissue Inhibitor of Metalloproteinases-1 and Promotes Its Cytokine-Like Activities
PLoS ONE·2014· 47 citedOpen Access
Interactions moléculaires TSP1 : CD47 : identification de nouveaux antagonistes à visée thérapeutique
2013
CD47 update: a multifaceted actor in the tumour microenvironment of potential therapeutic interest
British Journal of Pharmacology·2012· 170 citedOpen Access
LRP-1–CD44, a New Cell Surface Complex Regulating Tumor Cell Adhesion
Molecular and Cellular Biology·2012· 49 citedOpen Access

Frequent Co-authors

Stéphane Dedieu(16), Laurent Martiny(11), Christophe Schneider(9), Camille Boulagnon‐Rombi(7), Jérôme Devy(6), Émilie Sick(3), Benoît Langlois(3), Cathy Hachet(3), Marion David(3), Pascaline Lécorché(3), Hervé Emonard(3), Valérie Untereiner(3), Isabelle Proult(3), Stéphane Brézillon(3), Caroline Fichel(3), Marie-Danièle Diébold(3), Louis Thérêt(3), L. Verzeaux(2), Sébastien Almagro(2), Christine Terryn(2)